Kodo LifeScience at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Kodo LifeScience brings 2 presentations to ESGCT 2026 in Hamburg. Its contribution centres on plasmid DNA for cell and gene therapy manufacturing. Work includes a single-use platform that produces highly supercoiled plasmid at lower cost and a sensitive method for measuring leftover kanamycin in the product.
| Organization | ESGCT 2026 Attendance |
|---|---|
Kodo LifeScience Chennai, India | |
Cell and gene therapy development partner founded at IIT Madras, supplying GMP and GLP plasmid DNA, lentiviral vectors and process development. | Poster Wed Oct 28 1:30pm–3:30pm A scalable, cost efficient, single use GMP manufacturing platform to produce highly supercoiled plasmid DNA exceeding the global quality standards for raw materials used to manufacture clinical grade in-vivo viral vectors and mRNA vaccines Poster Thu Oct 29 2:00pm–4:00pm A sensitive RP-HPLC-PDA method with CNBF derivatization for the quantification of kanamycin residuals in plasmid DNA used in Cell and Gene Therapy (CGT) manufacturing |
Instantly find 20 buyers from Kodo LifeScience
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction